Related Experiment Videos

Hematopoietic colony-stimulating factors and dose intensity

W P Petros¹, W P Peters

¹Department of Medicine, Duke University Medical Center, Durham, NC 27710.

Seminars in Oncology

|February 1, 1993

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.

Bone marrow transplantation·2006

Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2005

The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer.

British journal of cancer·2005

High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow.

Bone marrow transplantation·2002

High-dose chemotherapy and hematopoietic stem cell transplantation for breast cancer: past or future?

Seminars in oncology·2001

See all related articles